16 Trademark Results found for "*VLA"

Also try searching for:

VLA*

Details	Status	Class/Description
AQIVLA BOEHRINGER INGELHEIM INTERNATIONAL GMBH 1747269 23 Sept 2015	REGISTERED on 23 Jul 2019	Pharmaceutical preparations for the treatment of cardiovascular diseas... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of gastrointestinal / diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of migraines; pharmaceutical preparations for the treatment of pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of stroke; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, cognitive disorders, schizophrenia, depression; pharmaceutical preparations for the treatment of substance abuse disorders, namely alcoholism and drug addiction; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of yeast infections; pharmaceutical preparations for the treatment of prostate disorders; pharmaceutical preparations for the treatment of pulmonary disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of gynecological disorders, namely premenstrual syndrome, endometreosis, yeast infections, menstrual irregularities; pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; pharmaceutical preparations namely smoking cessation preparations; pharmaceutical preparations namely tissue and skin repair preparations; pharmaceutical preparations namely acne medication; pharmaceutical preparations namely allergy medication; pharmaceutical preparations namely antacids; pharmaceutical preparations namely anthelmintics; pharmaceutical preparations namely antiarrhythmics; pharmaceutical preparations namely antibiotics; pharmaceutical preparations namely anticoagulants; pharmaceutical preparations namely anticonvulsants; pharmaceutical preparations namely antidepressants; pharmaceutical preparations namely antiemetics; pharmaceutical preparations namely antiflatulants; pharmaceutical preparations namely antihistamines; pharmaceutical preparations namely antihypertensives; pharmaceutical preparations namely anti-infectives; pharmaceutical preparations namely anti-inflammatories; pharmaceutical preparations namely antiparasitics; pharmaceutical preparations namely antibacterials; pharmaceutical preparations namely antifungals; pharmaceutical preparations namely antivirals; pharmaceutical preparations namely burn relief medication; pharmaceutical preparations namely calcium channel blockers; pharmaceutical preparations namely central nervous system depressants; pharmaceutical preparations namely central nervous system stimulants; pharmaceutical preparations namely cough treatment medication; pharmaceutical preparations namely diarrhea medication; pharmaceutical preparations namely gastrointestinal medication; pharmaceutical preparations namely glaucoma agents; pharmaceutical preparations namely hydrocortisone; pharmaceutical preparations namely hypnotic agents; pharmaceutical preparations namely sedatives, all aforementioned goods excluding nutritional supplements, dietary substances and dietetic substances
VLA LEVOLA HENGELO B.V. 1501616 28 Oct 2010	ABANDONED SECTION 36 on 7 Feb 2012	Dairy products. Class 029 Class 029 Meats and Processed Food Products Dairy products.
IMREVLA BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION) 1285741 11 Jan 2006	ABANDONED SECTION 40(3) on 29 Jul 2009	Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, metabolic disorders, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate; and diagnostic contrast imaging agents.
BANREVLA BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION) 1285749 11 Jan 2006	ABANDONED SECTION 40(3) on 4 Aug 2010	Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, metabolic disorders, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate; and diagnostic contrast imaging agents.
FAREVLA BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION) 1285744 11 Jan 2006	ABANDONED SECTION 40(3) on 2 Feb 2011	Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, metabolic disorders, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate; and diagnostic contrast imaging agents.
REVLA REVLA LIMITED 1261605 17 Jun 2005	EXPUNGED on 9 Jan 2024	Bicycle seats. Class 012 Class 012 Vehicles and Products for locomotion by land, air or water Bicycle seats.

REGISTERED

on 23 Jul 2019

AQIVLA

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

1747269 · 23 Sept 2015

005

Class 005

Pharmaceutical Products

Pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of gastrointestinal / diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of migraines; pharmaceutical preparations for the treatment of pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of stroke; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, cognitive disorders, schizophrenia, depression; pharmaceutical preparations for the treatment of substance abuse disorders, namely alcoholism and drug addiction; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of yeast infections; pharmaceutical preparations for the treatment of prostate disorders; pharmaceutical preparations for the treatment of pulmonary disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of gynecological disorders, namely premenstrual syndrome, endometreosis, yeast infections, menstrual irregularities; pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; pharmaceutical preparations namely smoking cessation preparations; pharmaceutical preparations namely tissue and skin repair preparations; pharmaceutical preparations namely acne medication; pharmaceutical preparations namely allergy medication; pharmaceutical preparations namely antacids; pharmaceutical preparations namely anthelmintics; pharmaceutical preparations namely antiarrhythmics; pharmaceutical preparations namely antibiotics; pharmaceutical preparations namely anticoagulants; pharmaceutical preparations namely anticonvulsants; pharmaceutical preparations namely antidepressants; pharmaceutical preparations namely antiemetics; pharmaceutical preparations namely antiflatulants; pharmaceutical preparations namely antihistamines; pharmaceutical preparations namely antihypertensives; pharmaceutical preparations namely anti-infectives; pharmaceutical preparations namely anti-inflammatories; pharmaceutical preparations namely antiparasitics; pharmaceutical preparations namely antibacterials; pharmaceutical preparations namely antifungals; pharmaceutical preparations namely antivirals; pharmaceutical preparations namely burn relief medication; pharmaceutical preparations namely calcium channel blockers; pharmaceutical preparations namely central nervous system depressants; pharmaceutical preparations namely central nervous system stimulants; pharmaceutical preparations namely cough treatment medication; pharmaceutical preparations namely diarrhea medication; pharmaceutical preparations namely gastrointestinal medication; pharmaceutical preparations namely glaucoma agents; pharmaceutical preparations namely hydrocortisone; pharmaceutical preparations namely hypnotic agents; pharmaceutical preparations namely sedatives, all aforementioned goods excluding nutritional supplements, dietary substances and dietetic substances

Pharmaceutical preparations for the treatment of cardiovascular diseas...

ABANDONED SECTION 36

on 7 Feb 2012

VLA

LEVOLA HENGELO B.V.

1501616 · 28 Oct 2010

029

Dairy products.

ABANDONED SECTION 40(3)

on 29 Jul 2009

IMREVLA

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

1285741 · 11 Jan 2006

005

Pharmaceutical preparations for human use for the treatment and preven...

ABANDONED SECTION 40(3)

on 4 Aug 2010

BANREVLA

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

1285749 · 11 Jan 2006

005

Pharmaceutical preparations for human use for the treatment and preven...

ABANDONED SECTION 40(3)

on 2 Feb 2011

FAREVLA

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

1285744 · 11 Jan 2006

005

Pharmaceutical preparations for human use for the treatment and preven...

EXPUNGED

on 9 Jan 2024

REVLA

REVLA LIMITED

1261605 · 17 Jun 2005

012

Bicycle seats.

Owners

Bristol-myers squibb company (a delaware corporation) (3)

Boehringer ingelheim international gmbh (1)

Bristol-myers squibb company (a delaware corporation) (1)

Enrico tosti (1)

Fresenius kabi deutschland gmbh (1)

Guylaine audet (1)

Iterum therapeutics international limited (1)

Jindi he (1)

Levola hengelo b.V. (1)

Megali souvla inc. a legal entity (1)

Categories

Class 5 (9)

Class 21 (2)

Class 43 (2)

Class 3 (1)

Class 9 (1)

Class 12 (1)

Class 18 (1)

Class 24 (1)

Class 29 (1)

Class 35 (1)

Correspondents

Gowling wlg (canada) llp (4)

Marks & clerk (2)

Cassan maclean ip agency inc. (1)

Gilbert's llp (1)

Goodmans llp (1)

Jamie bashtanyk (1)

Osler, hoskin & harcourt llp (1)

Riches, mckenzie & herbert llp (1)

Therrien couture joli-coeur s.E.N.C.R.L. (1)

Display

List View

Grid View

Apply for Trademark

Select countries to protect your logo Trademark

Trademark Name

Country Selected

Canada

C$500/ 1 class + gov fee

United States

C$138/ 1 class + gov fee

Canada

C$500/ 1 class + gov fee

Mexico

C$691/ 1 class + gov fee

European Union

C$970/ 1 class + gov fee

China

C$691/ 1 class + gov fee

South Korea

C$968/ 1 class + gov fee

Japan

C$1,107/ 1 class + gov fee

India

C$138/ 1 class + gov fee

United Kingdom

C$691/ 1 class + gov fee

Australia

C$415/ 1 class + gov fee

Israel

C$968/ 1 class + gov fee

United Arab Emirates

C$968/ 1 class + gov fee

New Zealand

C$968/ 1 class + gov fee

Brazil

C$691/ 1 class + gov fee

Taiwan

C$1,107/ 1 class + gov fee

Ukraine

C$1,107/ 1 class + gov fee

Indonesia

C$968/ 1 class + gov fee

South Africa

C$691/ 1 class + gov fee

Singapore

C$1,107/ 1 class + gov fee

Saudi Arabia

C$1,107/ 1 class + gov fee

Afghanistan

C$1,107/ 1 class + gov fee

Algeria

C$1,107/ 1 class + gov fee

Argentina

C$553/ 1 class + gov fee

Austria

C$1,245/ 1 class + gov fee

Bahrain

C$968/ 1 class + gov fee

Bangladesh

C$830/ 1 class + gov fee

Benelux

C$1,384/ 1 class + gov fee

Bhutan

C$1,245/ 1 class + gov fee

Bolivia

C$1,107/ 1 class + gov fee

Botswana

C$1,799/ 1 class + gov fee

British Virgin Islands

C$1,661/ 1 class + gov fee

Bulgaria

C$1,107/ 1 class + gov fee

Cambodia

C$1,107/ 1 class + gov fee

Chile

C$691/ 1 class + gov fee

Colombia

C$968/ 1 class + gov fee

Congo

C$1,661/ 1 class + gov fee

Costa Rica

C$1,245/ 1 class + gov fee

Croatia

C$1,245/ 1 class + gov fee

Cyprus

C$1,384/ 1 class + gov fee

Czech Republic

C$1,245/ 1 class + gov fee

Denmark

C$1,107/ 1 class + gov fee

Curacao

C$1,661/ 1 class + gov fee

Macau

C$968/ 1 class + gov fee

Dominican Republic

C$1,245/ 1 class + gov fee

Aruba

C$1,661/ 1 class + gov fee

Greenland

C$1,107/ 1 class + gov fee

Ecuador

C$1,107/ 1 class + gov fee

Egypt

C$968/ 1 class + gov fee

El Salvador

C$1,107/ 1 class + gov fee

Ethiopia

C$1,522/ 1 class + gov fee

France

C$1,245/ 1 class + gov fee

Gaza

C$1,107/ 1 class + gov fee

Germany

C$1,245/ 1 class + gov fee

Greece

C$1,107/ 1 class + gov fee

Guatemala

C$1,245/ 1 class + gov fee

Haiti

C$1,245/ 1 class + gov fee

Honduras

C$1,245/ 1 class + gov fee

Hong Kong (SAR)

C$1,245/ 1 class + gov fee

Hungary

C$1,522/ 1 class + gov fee

Iraq

C$2,076/ 1 class + gov fee

Italy

C$1,245/ 1 class + gov fee

Jordan

C$1,107/ 1 class + gov fee

Kazakhstan

C$1,107/ 1 class + gov fee

Kenya

C$1,245/ 1 class + gov fee

Kuwait

C$1,107/ 1 class + gov fee

Laos

C$968/ 1 class + gov fee

Lebanon

C$1,384/ 1 class + gov fee

Lesotho

C$1,661/ 1 class + gov fee

Libya

C$1,245/ 1 class + gov fee

Madrid Protocol (WIPO)

C$2,769/ 1 class + gov fee

Malawi

C$1,522/ 1 class + gov fee

Malaysia

C$968/ 1 class + gov fee

Maldives

C$1,384/ 1 class + gov fee

Morocco

C$1,384/ 1 class + gov fee

Mozambique

C$1,245/ 1 class + gov fee

Myanmar

C$1,107/ 1 class + gov fee

Namibia

C$1,107/ 1 class + gov fee

Nepal

C$968/ 1 class + gov fee

Nicaragua

C$1,245/ 1 class + gov fee

Norway

C$1,245/ 1 class + gov fee

Oman

C$1,522/ 1 class + gov fee

Pakistan

C$1,107/ 1 class + gov fee

Panama

C$1,245/ 1 class + gov fee

Paraguay

C$1,245/ 1 class + gov fee

Peru

C$1,107/ 1 class + gov fee

Philippines

C$1,245/ 1 class + gov fee

Poland

C$691/ 1 class + gov fee

Portugal

C$1,245/ 1 class + gov fee

Puerto Rico

C$1,245/ 1 class + gov fee

Qatar

C$1,107/ 1 class + gov fee

Romania

C$1,245/ 1 class + gov fee

Serbia

C$1,245/ 1 class + gov fee

Slovakia

C$1,245/ 1 class + gov fee

Spain

C$1,245/ 1 class + gov fee

Sri Lanka

C$968/ 1 class + gov fee

Swaziland

C$1,799/ 1 class + gov fee

Sweden

C$1,107/ 1 class + gov fee

Switzerland

C$1,245/ 1 class + gov fee

Thailand

C$1,107/ 1 class + gov fee

Tunisia

C$1,245/ 1 class + gov fee

Turkey

C$1,107/ 1 class + gov fee

Uganda

C$968/ 1 class + gov fee

United Republic of Tanzania

C$968/ 1 class + gov fee

Uruguay

C$1,107/ 1 class + gov fee

Venezuela

C$1,245/ 1 class + gov fee

Vietnam

C$1,107/ 1 class + gov fee

West Bank, Palestine

C$1,107/ 1 class + gov fee

Yemen

C$2,353/ 1 class + gov fee

Albania

C$1,245/ 1 class + gov fee

Andorra

C$1,245/ 1 class + gov fee

Angola

C$1,799/ 1 class + gov fee

Antigua and Barbuda

C$1,661/ 1 class + gov fee

Armenia

C$1,107/ 1 class + gov fee

Azerbaijan

C$1,107/ 1 class + gov fee

Bahamas

C$1,938/ 1 class + gov fee

Barbados

C$1,799/ 1 class + gov fee

Belgium

C$1,384/ 1 class + gov fee

Belize

C$1,799/ 1 class + gov fee

Benin

C$1,107/ 1 class + gov fee

Bosnia and Herzegovina

C$1,384/ 1 class + gov fee

Brunei

C$1,799/ 1 class + gov fee

Burkina Faso

C$1,107/ 1 class + gov fee

Burundi

C$1,661/ 1 class + gov fee

Cabo Verde

C$1,245/ 1 class + gov fee

Cameroon

C$1,107/ 1 class + gov fee

Central African Republic (CAR)

C$1,107/ 1 class + gov fee

Chad

C$1,107/ 1 class + gov fee

Comoros

C$1,107/ 1 class + gov fee

Cote d'Ivoire

C$1,107/ 1 class + gov fee

Czechia

C$1,384/ 1 class + gov fee

Djibouti

C$1,661/ 1 class + gov fee

Dominica

C$1,799/ 1 class + gov fee

Equatorial Guinea

C$1,107/ 1 class + gov fee

Eritrea

C$1,384/ 1 class + gov fee

Estonia

C$1,799/ 1 class + gov fee

Eswatini

C$1,799/ 1 class + gov fee

Fiji

C$1,245/ 1 class + gov fee

Finland

C$968/ 1 class + gov fee

Gabon

C$1,107/ 1 class + gov fee

Gambia

C$1,245/ 1 class + gov fee

Georgia

C$1,107/ 1 class + gov fee

Ghana

C$1,384/ 1 class + gov fee

Grenada

C$1,799/ 1 class + gov fee

Guinea

C$1,107/ 1 class + gov fee

Guinea-Bissau

C$1,107/ 1 class + gov fee

Guyana

C$1,799/ 1 class + gov fee

Iceland

C$1,799/ 1 class + gov fee

Ireland

C$1,245/ 1 class + gov fee

Jamaica

C$1,661/ 1 class + gov fee

Kiribati

C$1,384/ 1 class + gov fee

Kosovo

C$1,245/ 1 class + gov fee

Kyrgyzstan

C$1,245/ 1 class + gov fee

Latvia

C$968/ 1 class + gov fee

Liberia

C$1,384/ 1 class + gov fee

Liechtenstein

C$1,384/ 1 class + gov fee

Lithuania

C$968/ 1 class + gov fee

Luxembourg

C$1,384/ 1 class + gov fee

Madagascar

C$1,384/ 1 class + gov fee

Mali

C$1,107/ 1 class + gov fee

Malta

C$830/ 1 class + gov fee

Marshall Islands

C$1,384/ 1 class + gov fee

Mauritania

C$1,107/ 1 class + gov fee

Mauritius

C$1,384/ 1 class + gov fee

Micronesia

C$1,384/ 1 class + gov fee

Moldova

C$1,384/ 1 class + gov fee

Monaco

C$1,938/ 1 class + gov fee

Mongolia

C$830/ 1 class + gov fee

Montenegro

C$1,245/ 1 class + gov fee

Nauru

C$1,384/ 1 class + gov fee

Netherlands

C$1,384/ 1 class + gov fee

Niger

C$1,107/ 1 class + gov fee

Nigeria

C$553/ 1 class + gov fee

North Macedonia

C$1,245/ 1 class + gov fee

Palau

C$1,384/ 1 class + gov fee

Palestine

C$1,384/ 1 class + gov fee

Papua New Guinea

C$1,107/ 1 class + gov fee

Rwanda

C$1,384/ 1 class + gov fee

Saint Kitts and Nevis

C$1,799/ 1 class + gov fee

Saint Lucia

C$1,799/ 1 class + gov fee

Saint Vincent and the Grenadines

C$1,799/ 1 class + gov fee

Samoa

C$1,661/ 1 class + gov fee

San Marino

C$1,384/ 1 class + gov fee

Sao Tome and Principe

C$1,384/ 1 class + gov fee

Senegal

C$1,107/ 1 class + gov fee

Seychelles

C$1,384/ 1 class + gov fee

Sierra Leone

C$1,384/ 1 class + gov fee

Slovenia

C$1,245/ 1 class + gov fee

Solomon Islands

C$1,384/ 1 class + gov fee

Somalia

C$1,384/ 1 class + gov fee

South Sudan

C$1,384/ 1 class + gov fee

Suriname

C$2,215/ 1 class + gov fee

Tajikistan

C$1,107/ 1 class + gov fee

Tanzania

C$968/ 1 class + gov fee

Timor-Leste

C$1,384/ 1 class + gov fee

Togo

C$1,107/ 1 class + gov fee

Tonga

C$1,799/ 1 class + gov fee

Trinidad and Tobago

C$1,661/ 1 class + gov fee

Turkmenistan

C$1,107/ 1 class + gov fee

Tuvalu

C$1,384/ 1 class + gov fee

Uzbekistan

C$968/ 1 class + gov fee

Vanuatu

C$1,661/ 1 class + gov fee

Zambia

C$1,245/ 1 class + gov fee

Zimbabwe

C$1,245/ 1 class + gov fee

OAPI

C$1,245/ 1 class + gov fee

ARIPO

C$1,384/ 1 class + gov fee

End of search results

Page 2 of 2